Výsledky vyhledávání - "Mark Wingertzahn"

Akademický článek

Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study

Autor: John P. Haran, Jose C. Pinero, Yan Zheng, Norma Alonzo Palma, Mark Wingertzahn

Publikováno v: Trials, Vol 22, Iss 1, Pp 1-5 (2021)

Abstract Objectives These 2 parallel studies (K031 and K032) aim to evaluate the safety of KB109 in addition to supportive self-care (SSC) compared with SSC alone in outpatients with mild to moderate coronavirus disease 2019 (COVID-19). KB109 is a no

Externí odkaz: https://doaj.org/article/07720676b90f40a69bfd2dbe01e8fe85

Zobrazit plný text záznamu

THE SYNTHETIC GLYCAN KB295 OPTIMIZES MICROBIOME COMPOSITION AND FUNCTION IN ULCERATIVE COLITIS – RESULTS FROM A PROOF OF PRINCIPLE HUMAN STUDY

Autor: Jeffrey Meisner, Toni Bransford, Kelsey Miller, Jackson Lee, Adarsh Jose, Michael Giuggio, Megan McComb, Eric Humphries, Madeline Rosini, Mark Wingertzahn, Fergus Shanahan, Johan E T van Hylckama Vlieg, Mark Dowling

Publikováno v: Gastroenterology. 162:S70-S71

The pathogenesis of ulcerative colitis (UC) involves genetic susceptibility, immune-mediated tissue injury and environmental factors including disturbances of the gut microbiota. Nearly all current approved therapies modify host immunity, rather than

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29f209b75a2337464c1f49470ef02f2c
https://doi.org/10.1053/j.gastro.2021.12.150

Zobrazit plný text záznamu

Virtualized Clinical Studies to Assess the Natural History and Impact of Gut Microbiome Modulation in Non-Hospitalized Patients with Mild to Moderate COVID-19 a Randomized, Open-Label, Prospective Study with a Parallel Group Study Evaluating the Physiologic Effects of KB109 on Gut Microbiota Structure and Function: A Structured Summary of a Study Protocol for a Randomized Controlled Study

Autor: Yan Zheng, Jose C. Pinero, John P. Haran, Mark Wingertzahn, Norma Alonzo Palma

Publikováno v: Trials, Vol 22, Iss 1, Pp 1-5 (2021)
Trials

Objectives These 2 parallel studies (K031 and K032) aim to evaluate the safety of KB109 in addition to supportive self-care (SSC) compared with SSC alone in outpatients with mild to moderate coronavirus disease 2019 (COVID-19). KB109 is a novel synth

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3194e64e5bafb853f2f0ee8a074ae52
https://doi.org/10.21203/rs.3.rs-275217/v1

Zobrazit plný text záznamu

946: KB295, A SYNTHETIC GLYCAN, AUGMENTS GUT MICROBIOME COMPOSITION AND FUNCTION IN ULCERATIVE COLITIS: UPDATED RESULTS FROM A PROOF OF PRINCIPAL HUMAN STUDY

Autor: Jeffrey Meisner, Kelsey Miller, Jackson Lee, Adarsh Jose, Michael Giuggio, Megan McComb, Eric Humphries, Madeline Rosini, Mark Wingertzahn, Fergus Shanahan, Mark Dowling, Johan E.T. van Hylckama Vlieg

Publikováno v: Gastroenterology. 162:S-221

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::43bf564f0840f0bfb10ec89f49b483c0
https://doi.org/10.1016/s0016-5085(22)60530-4

Zobrazit plný text záznamu

Patient-reported comorbidity affects symptom duration in non-hospitalized patients with mild to moderate COVID-19 in a clinical study

Autor: John P Haran, Yan Zheng, Norma Alonzo-Palma, Mark Wingertzahn

Publikováno v: The Journal of Immunology. 206:62.14-62.14

Background: Most COVID-19 cases in the US are managed via outpatient care, yet the outpatient natural history of COVID-19 is not well understood. We assessed outpatient natural history of COVID-19 as part of a clinical food study evaluating KB109 saf

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a826c074cf02246cfbdce55ec552763c
https://doi.org/10.4049/jimmunol.206.supp.62.14

Zobrazit plný text záznamu

A randomized, double-blind study to evaluate the safety and tolerability of KB174, a novel synthetic glycan, in patients with well-compensated cirrhosis

Autor: Bal Raj Bhandari, Jeffrey Cehelsky, Yan Zheng, Mark Wingertzahn, Norma Palma, Robert S Mittleman

Publikováno v: Journal of Hepatology. 73:S699

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::69187c3042152b1b526e9f5c9fc3834e
https://doi.org/10.1016/s0168-8278(20)31858-4

Zobrazit plný text záznamu

Akademický článek

Efficacy and Safety of Once-Daily Ciclesonide Nasal Spray in Children With Allergic Rhinitis.

Autor: William E. Berger, Anjuli Nayak, Bobby Q. Lanier, Harold B. Kaiser, Craig LaForce, Patrick Darken, Nancy Hall, Mark Wingertzahn

Publikováno v: Pediatric Asthma, Allergy & Immunology; Aug2008, Vol. 21 Issue 2, p73-82, 10p

Zobrazit plný text záznamu

Akademický článek

Safety of Once-Daily Ciclesonide Nasal Spray in Children 2 to 5 Years of Age with Perennial Allergic Rhinitis.

Autor: Kenneth Kim, Michael Weiswasser, Ruediger Nave, Paul Ratner, Anjuli Nayak, Jerry Herron, Nancy Hall, Mark Wingertzahn

Publikováno v: Pediatric Asthma, Allergy & Immunology; Dec2007, Vol. 20 Issue 4, p229-242, 14p

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání